Menu
Fechar
HRS4R
Vull donar

JOHANA ALEJANDRA DIAZ SANTA

Hematologia
Firma
JOHANA ALEJANDRA DIAZ-SANTA
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2
Projectes
Publicacions

Projectes

Hematologia

Ajuts per donar suport a les activitats dels grups de recerca de Catalunya (SGR-Cat 2021) - Hematologia

Codi oficial: 6822ZB3KJ Data inici: 01/01/2022 Data fi: 30/06/2025 Investigador/a principal: DAVID GALLARDO GIRALT Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA

Publicacions

Muñoz NG, Ortega S, Solanich X, Cid J, Díaz M, Moreno AB, Ancochea Á, Santos M, Hernández I, Sanchez JM, Luaña A, García J, Escoda L, Medina L, Ferrer GJ, López J, Céspedes R, Díaz JA, Pons V, Valcárcel D, Grifols JR

Diagnosis and clinical management of thrombotic thrombocytopenic purpura (TTP): a consensus statement from the TTP Catalan group.

BLOOD TRANSFUSION, 2024, 22, 176-184 dx.doi.org/10.2450/BloodTransfus.522
Gonzalez-Lopez TJ, Bermejo N, Cardesa-Cabrera R, Martínez V, Aguilar-Monserrate G, Pérez Segura G, García AD, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galán Alvarez P, Benet Campos C, Marcellini-Antonio S, Jimenez-Bárcenas R, Martínez-Carballeira D, de Miguel Llorente D, Perona Blázquez Á, González-Gascón-Y-Marín I, Lopez-Ansoar E, Alonso Alonso JM, Bengochea-Casado ML, Díaz Gálvez FJ, Moretó A, Moreno G, Hernández-Martin R, de Cabo E, Davila-Valls J, Cuesta A, Pastoriza Cruz C, Hermida G, García C, Pozas-Mañas MA, Aguilar-Franco C, Fernandez-Jimenez D, Navas-Elorza B, López-Santamaría Castro C, Lorenzo Vizcaya A, Ortín X, Pintos MG, Piernas S, Díaz-Santa J, Soto-Ortega I Dr, Provan D, García-Donas Gabaldón G

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Blood, 2024, 144, 646-656 dx.doi.org/10.1182/blood.2024024250
Díaz-Santa J, Rodríguez-Romanos R, Coll R, Osca G, Pratcorona M, González-Bártulos M, Garrido A, Angona A, Talarn C, Tormo M, Arnan M, Vives S, Salamero O, Tuset E, Lloveras N, Díez I, Zamora L, Bargay J, Sampol A, Cruz D, Vila J, Sitges M, Garcia A, Vall-Llovera F, Esteve J, Sierra J, Gallardo D

5 '-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109, 755-764 dx.doi.org/10.1111/ejh.13862
Vilorio-Marqués L, Castañón Fernández C, Mora E, Gutiérrez L, Rey Bua B, Jiménez Lorenzo MJ, Díaz Beya M, Vara Pampliega M, Molero A, Sánchez-García J, Calabuig M, Cedena MT, Chen-Liang T, Díaz Santa JA, Padilla I, Hernández F, Díez R, Asensi P, Xicoy B, Sanz G, Valcárcel D, Diez-Campelo M, Bernal T

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.

Therapeutic Advances in Hematology, 2022, 13 dx.doi.org/10.1177/20406207221127547
Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy

Leukemia, 2020, 34, 2925-2933 dx.doi.org/10.1038/s41375-020-0784-2

Formulari de contacte

Coneix l’IDIBGI!

 menu